These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26062823)

  • 1. STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.
    Subbiah V; McMahon C; Patel S; Zinner R; Silva EG; Elvin JA; Subbiah IM; Ohaji C; Ganeshan DM; Anand D; Levenback CF; Berry J; Brennan T; Chmielecki J; Chalmers ZR; Mayfield J; Miller VA; Stephens PJ; Ross JS; Ali SM
    J Hematol Oncol; 2015 Jun; 8():66. PubMed ID: 26062823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1.
    Haimes JD; Stewart CJR; Kudlow BA; Culver BP; Meng B; Koay E; Whitehouse A; Cope N; Lee JC; Ng T; McCluggage WG; Lee CH
    Am J Surg Pathol; 2017 Jun; 41(6):773-780. PubMed ID: 28490045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALK Is a Specific Diagnostic Marker for Inflammatory Myofibroblastic Tumor of the Uterus.
    Mohammad N; Haimes JD; Mishkin S; Kudlow BA; Leong MY; Chew SH; Koay E; Whitehouse A; Cope N; Ali RH; Köbel M; Stewart CJR; McCluggage WG; Lee CH
    Am J Surg Pathol; 2018 Oct; 42(10):1353-1359. PubMed ID: 30015720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALK-rearranged Tumors Are Highly Enriched in the STUMP Subcategory of Uterine Tumors.
    Devereaux KA; Kunder CA; Longacre TA
    Am J Surg Pathol; 2019 Jan; 43(1):64-74. PubMed ID: 29794871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical and selected genetic reflex testing of all uterine leiomyosarcomas and STUMPs for ALK gene rearrangement may provide an effective screening tool in identifying uterine ALK-rearranged mesenchymal tumors.
    Ptáková N; Miesbauerová M; Kosťun J; Grossmann P; Šidlová H; Pavelka J; Presl J; Alaghehbandan R; Bouda J; Ondič O
    Virchows Arch; 2018 Nov; 473(5):583-590. PubMed ID: 30116888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNS1-ALK Fusion in a Recurrent, Metastatic Uterine Mesenchymal Tumor Originally Diagnosed as Leiomyosarcoma.
    Lee J; Singh A; Ali SM; Lin DI; Klempner SJ
    Acta Med Acad; 2019 Apr; 48(1):116-120. PubMed ID: 31264439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALK Immunoexpression is Specific for Inflammatory Myofibroblastic Tumor Among Vulvovaginal Mesenchymal Neoplasms.
    Bowman CJ; Medeiros F; Fadare O; Sangoi AR; Horvai AE; Devine WP; McCluggage WG; Rabban JT
    Int J Gynecol Pathol; 2023 Jan; 42(1):1-10. PubMed ID: 35180768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
    Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
    Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report.
    Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y
    J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory myofibroblastic tumor of the uterus - case report.
    Štiková Z; Ptáková N; Horáková M; Kosťun J; Ondič O
    Cesk Patol; 2019; 55(4):239-243. PubMed ID: 31842556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion.
    Cheek EH; Fadra N; Jackson RA; Davila JI; Sukov WR; Uckerman MT; Clayton A; Keeney GL; Halling KC; Torres-Mora J; Schoolmeester JK
    Hum Pathol; 2020 Mar; 97():29-39. PubMed ID: 31917155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract.
    Fuehrer NE; Keeney GL; Ketterling RP; Knudson RA; Bell DA
    Arch Pathol Lab Med; 2012 Jun; 136(6):623-6. PubMed ID: 22646268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leiomyoma-like Morphology in Metastatic Uterine Inflammatory Myofibroblastic Tumors.
    Devins KM; Samore W; Nielsen GP; Deshpande V; Oliva E
    Mod Pathol; 2023 Jun; 36(6):100143. PubMed ID: 36806735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors.
    Rabban JT; Zaloudek CJ; Shekitka KM; Tavassoli FA
    Am J Surg Pathol; 2005 Oct; 29(10):1348-55. PubMed ID: 16160478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions.
    Lovly CM; Gupta A; Lipson D; Otto G; Brennan T; Chung CT; Borinstein SC; Ross JS; Stephens PJ; Miller VA; Coffin CM
    Cancer Discov; 2014 Aug; 4(8):889-95. PubMed ID: 24875859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine Inflammatory Myofibroblastic Tumor Showing an Atypical ALK Signal Pattern by FISH and DES-ALK Fusion by RNA Sequencing: A Case Report.
    Zarei S; Abdul-Karim FW; Chase DM; Astbury C; Policarpio-Nicolas MLC
    Int J Gynecol Pathol; 2020 Mar; 39(2):152-156. PubMed ID: 30741845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course.
    Parra-Herran C; Quick CM; Howitt BE; Dal Cin P; Quade BJ; Nucci MR
    Am J Surg Pathol; 2015 Feb; 39(2):157-68. PubMed ID: 25321329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases.
    Li XQ; Hisaoka M; Shi DR; Zhu XZ; Hashimoto H
    Hum Pathol; 2004 Jun; 35(6):711-21. PubMed ID: 15188137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions.
    Devereaux KA; Fitzpatrick MB; Hartinger S; Jones C; Kunder CA; Longacre TA
    Am J Surg Pathol; 2020 Jul; 44(7):970-981. PubMed ID: 32271187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Clinical response to anaplastic lymphoma kinase inhibitor-based targeted therapy in uterine inflammatory myofibroblastic tumor harboring
    Zhao T; Zhang X; Liu X; Ren M; Cheng Y; Wang J; Luo Z
    Front Oncol; 2023; 13():1147974. PubMed ID: 37035208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.